Wednesday, 08 December 2021 12:35 GMT

Regenerative medicine market is expected to grow at a CAGR of 23%-25% An exclusive market research report by Lucintel

(MENAFN- GetNews)

“Trends and Forecast for the Global Regenerative Medicine Market” Trends, opportunities and forecast in regenerative medicine market to 2025 by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals

Lucintel's latest market report analyzed that regenerative medicine provides attractive opportunities in the orthopedic, wound care, cardiovascular, and thoracic applications. The regenerative medicine market is expected to grow at a CAGR of 23%-25%. In this market, cell-based immunology and cell therapy products are the largest segment by product, whereas a musculoskeletal disorder is largest by application.

Download Brochure of this report by clicking on Based on product, the regenerative medicine market is segmented into cell-based immunotherapy and cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products. The cell-based immunotherapy and cell therapy products segment accounted for the largest share of the market in 2020 due to increasing government support for research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.

Browse in-depth TOC on“Regenerative Medicine Market”

XX – Tables

XX – Figures

150 – Pages

The regenerative medicine market is marked by the presence of several big and small players. Some of the prominent players offering regenerative medicine include Kite Pharma, Novartis, Vericel, Integra LifeSciences, Wright Medical, MiMedx, Osiris Therapeutics, Stryker, Spark Therapeutics, and Zimmer Biomet.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link .

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting , M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit .


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.